Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-22

Clinical Trial Update: Validation of Bulbicam for DR- and AMD-patients

View source ↗

Summary

This clinical trial update reports the completion of validation studies for Bulbicam in patients with diabetic retinopathy and age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bulbicam

Snippet

Sponsor: Meddoc | Conditions: Diabetic Retinopathy, Age-Related Macular Degeneration | Status: COMPLETED